REGN vs JNJ: Which Stock is Better?

Side-by-side comparison of Regeneron Pharmaceuticals Inc and Johnson & Johnson in 2026

Comparison Updated:

REGN

Regeneron Pharmaceuticals Inc

$662.88

JNJ

Johnson & Johnson

$263.40

Key Metrics Comparison

MetricREGNJNJWinner
Market Cap$59.10B$375.37BJNJ
P/E Ratio13.9117.35REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze REGN

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is REGN or JNJ a better investment?

Comparing REGN and JNJ: Regeneron Pharmaceuticals Inc has a market cap of $59.10B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between REGN and JNJ?

REGN (Regeneron Pharmaceuticals Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: REGN or JNJ?

Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 17.4x).

Which is growing faster: REGN or JNJ?

Both REGN and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: REGN or JNJ?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: REGN or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $59.10B for REGN.

Should I buy REGN or JNJ in 2026?

Both REGN and JNJ have investment merit. REGN trades at $662.88 while JNJ trades at $263.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between REGN and JNJ stock?

Key differences: Market Cap ($59.10B vs $375.37B), P/E Ratio (13.9x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy REGN or JNJ in 2026?

The choice between REGN and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between REGN and JNJ?

REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.

Popular Stock Comparisons